Supn stock forecast zvmbglb

Supn stock forecast

21.02.2021

Bothman16741

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions. Supernus Pharmaceuticals, Inc. Common Stock (SUPN) Analyst ... Find the latest analyst research for Supernus Pharmaceuticals, Inc. Common Stock (SUPN) at Nasdaq.com. Supernus Pharmaceuticals, Inc. - SUPN - Stock Price Today ... View Supernus Pharmaceuticals, Inc. SUPN investment & stock information. Get the latest Supernus Pharmaceuticals, Inc. SUPN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

The latest Supernus Pharmaceuticals Inc US$0.001 share price. View recent trades and Supernus Pharmaceuticals Inc (SUPN) US$0.001. Sell:$18.16 Buy: $18.20 Important Documents. There are no documents available for this stock.

SUPN -- Is Its Stock Price A Worthy Investment? Learn More. SUPN Stock Summary. With a one year PEG ratio of 105.07, Supernus Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 76.1% of US stocks. SUPN Stock Quote - Supernus Pharmaceuticals, Inc. Common ... Stock quote for Supernus Pharmaceuticals, Inc. Common Stock Common Stock (SUPN) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

Predict and forecast SUPN (Supernus Pharmaceuticals Inc) plus see real-time data from other investors. Start making your PredictWallStreet stock market predictions today.

View today's stock price, news and analysis for Supernus Pharmaceuticals Inc. (SUPN). Barron's also provides information on historical stock ratings, target prices, company earnings, market SUPN | Supernus Pharmaceuticals Inc. Stock Price & News - WSJ

Supernus Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is

Stock Comparison: Compare Supernus Pharmaceuticals, Inc ... Online Stock Comparison - Compare Supernus Pharmaceuticals, Inc. (SUPN) to four other stocks with NASDAQ.com's stock comparison tool. SUPN Price Target | Supernus Pharmaceuticals Stock ... See Supernus Pharmaceuticals price target based on 2 analysts offering 12 month price targets for Supernus Pharmaceuticals in the last 3 months. The average price target is $22.50 with a high forecast of $25.00 and a low forecast of $20.00. The average price target represents a … SUPN - Supernus Pharm Stock Price - Barchart.com

Supernus Pharmaceuticals, Inc. Common Stock (SUPN ...

Amazon Stock Price Prediction: The consensus among analysts is that Amazon is a good buy and that only big things are ahead for the company, but there are SUPN - Supernus Pharmaceuticals Inc Stock quote - … Find real-time SUPN - Supernus Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. SUPN - Supernus Pharmaceuticals Inc Stock quote - CNNMoney.com Markets Supernus Pharmaceuticals, Inc. Common Stock (SUPN ... Find the latest Earnings Report Date for Supernus Pharmaceuticals, Inc. Common Stock (SUPN) at Nasdaq.com.